MedPath

Gentak

GENTAK Gentamicin Sulfate Ophthalmic Ointment USP,03%

Approved
Approval ID

812a98bb-fae1-48cb-e053-2991aa0abee7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 10, 2021

Manufacturers
FDA

NuCare Pharmaceuticals,Inc.

DUNS: 010632300

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Gentamicin Sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68071-1513
Application NumberANDA064093
Product Classification
M
Marketing Category
C73584
G
Generic Name
Gentamicin Sulfate
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateFebruary 10, 2021
FDA Product Classification

INGREDIENTS (5)

PETROLATUMInactive
Code: 4T6H12BN9U
Classification: IACT
METHYLPARABENInactive
Quantity: 0.5 mg in 1 g
Code: A2I8C7HI9T
Classification: IACT
PROPYLPARABENInactive
Quantity: 0.1 mg in 1 g
Code: Z8IX2SC1OH
Classification: IACT
MINERAL OILInactive
Code: T5L8T28FGP
Classification: IACT
GENTAMICIN SULFATEActive
Quantity: 3 mg in 1 g
Code: 8X7386QRLV
Classification: ACTIM

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 2/5/2019

pdp

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 3/2/2012

INDICATIONS AND USAGE

Gentamicin sulfate ophthalmic ointment is indicated in the topical treatment of ocular bacterial infections including conjunctivitis, keratitis, keratoconjunctivitis, corneal ulcers, blepharitis, blepharonconjunctivitis: acute meibomianitis, and dacryocystitis, caused by susceptible strains of the following microorganisms:

  • Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus pneumoniae, Enterobacter aerogenes, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, and Serratia marcescens.

CONTRAINDICATIONS SECTION

LOINC: 34070-3Updated: 3/2/2012

CONTRAINDICATIONS

Gentamicin sulfate ophthalmic ointment is con-traindicated in patients with known hypersensitivity to any of the components.

ADVERSE REACTIONS SECTION

LOINC: 34084-4Updated: 3/2/2012

ADVERSE REACTIONS

Bacterial and fungal corneal ulcers have developed during treatment with gentamicin ophthalmic preparations.

The most frequently reported adverse reactions are ocular burning and irritation upon drug instillation, non-specific conjunctivitis, conjunctival epithelial defects and conjunctival hyperemia.

Other adverse reactions which have occurred rarely are allergic reactions, thrombocytopenic purpura and hallucinations.

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 3/2/2012

Sterile

Rx only

DESCRIPTION SECTION

LOINC: 34089-3Updated: 8/3/2018

DESCRIPTION

GENTAK ® Gentamicin sulfate is a water soluble antibiotic of the aminoglycoside group.

Gentamicin sulfate ophthalmic ointment is a sterile ointment for ophthalmic use. Each gram contains gentamicin sulfate equivalent to 3 mg gentamicin in a base of white petrolatum and mineral oil, with methylparaben and propylparaben as preservatives.

Gentamicin is obtained from cultures of Micromonospora purpurea. It is a mixture of the sulfate salts of gentamicin C 1 C 2, and C 1A. All three components appear to have similar antimicrobial activities. Gentamicin sulfate occurs as a white to buff powder and is soluble in water and insoluble in alcohol. The structural formula is as follows:

Structural Formula

CLINICAL PHARMACOLOGY SECTION

LOINC: 34090-1Updated: 3/2/2012

CLINICAL PHARMACOLOGY

Microbiology: Gentamicin sulfate is active in vitro against many strains of the following microorganisms:

  • Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus pneumoniae, Enterobacter aerogenes, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, and Serratia marcescens.

WARNINGS SECTION

LOINC: 34071-1Updated: 3/2/2012

WARNINGS

NOT FOR INJECTION INTO THE EYE.

Gentamicin sulfate ophthalmic ointment is not for injection. It should never be injected subconjunctivally, nor should it be directly introduced into the anterior chamber of the eye.

PRECAUTIONS SECTION

LOINC: 42232-9Updated: 3/2/2012

PRECAUTIONS

General: Prolonged use of topical antibiotics may give rise to overgrowth of nonsusceptible organisms including fungi. Bacterial resistance to gentamicin may also develop. If purulent discharge, inflammation or pain becomes aggravated, the patient should discontinue use of the medication and consult a physician.

If irritation or hypersensitivity to any component of the drug develops, the patient should discontinue use of this preparation and appropriate therapy should be instituted.

Ophthalmic ointments may retard corneal healing.

Information for patients: To avoid contamination, do not touch tip of container to the eye, eyelid or any surface.

Carcinogenesis, Mutagenesis, Impairment of Fertility: There are no published carcinogenicity or impairment of fertility studies on gentamicin. Aminoglycoside antibiotics have been found to be non-mutagenic.

Pregnancy: Pregnancy Category C. Gentamicin has been shown to depress body weights, kidney weights and median glomerular counts in newborn rats when administered systemically to pregnant rats in daily doses approximately 500 times the maximum recommended ophthalmic human dose. There are no adequate and well-controlled studies in pregnant women. Gentamicin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Pediatric Use: Safety and effectiveness in neonates have not been established.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 3/2/2012

DOSAGE AND ADMINISTRATION

Apply a small amount (approximately 1/2 inch ribbon) of ointment to the affected eye(s) two or three times a day.

HOW SUPPLIED SECTION

LOINC: 34069-5Updated: 3/2/2012

HOW SUPPLIED

GENTAK ® Gentamicin sulfate ophthalmic ointment USP, 0.3% is supplied in 3.5 g , box of one.

(NDC 68071-1513-5)

STORAGE: Store at 2° to 30°C (36° to 86°F).

Akorn
Manufactured by: Akorn, Inc.
Lake Forest, IL 60045
GKO00N Rev. 06/16

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Gentak - FDA Drug Approval Details